A novel monkey proarrhythmia model that can predict the drug-induced torsades de pointes in clinical practice

被引:0
|
作者
Satoh, Y
Sugiyama, A
Takahara, A
Sakamoto, K
Sakamoto, M
Nomura, M
Hashimoto, K
机构
[1] Univ Yamanashi, Dept Pharmacol, Yamanashi 4093898, Japan
[2] Koshu Rehabil Hosp, Yamanashi 4060032, Japan
[3] Yamanashi Res Ctr Clin Pharmacol, Yamanashi 4060023, Japan
[4] Ina Res Inc, Safety Res Ctr, Nagano 3994501, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:223P / 223P
页数:1
相关论文
共 50 条
  • [31] Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes
    Ramirez, A. H.
    Shaffer, C. M.
    Delaney, J. T.
    Sexton, D. P.
    Levy, S. E.
    Rieder, M. J.
    Nickerson, D. A.
    George, A. L., Jr.
    Roden, D. M.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (04): : 325 - 329
  • [32] Pathophysiology of drug-induced torsades de pointes and strategies for non-clinical detection of cardiotoxic drugs
    Bass, Alan Stuart
    Zhou, Ying-Ying
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 10 - 10
  • [33] Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy
    Turner, J. Rick
    Rodriguez, Ignacio
    Mantovani, Emily
    Gintant, Gary
    Kowey, Peter R.
    Klotzbaugh, Ralph J.
    Prasad, Krishna
    Sager, Philip T.
    Stockbridge, Norman
    Strnadova, Colette
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (08): : 997 - 1012
  • [34] Seizure-induced Torsades de pointes:In a canine drug-induced long-QT1 model
    van der Linde, Henk
    Kreir, Mohamed
    Teisman, Ard
    Gallacher, David J.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 111
  • [35] Validation of a model for predicting drug-induced torsades de pointes: The risky business of assessing arrhythmogenic potential
    Yamada, Kathryn A.
    Nerbonne, Jeanne M.
    HEART RHYTHM, 2006, 3 (08) : 957 - 958
  • [36] Drug-Induced And Self-Terminating Torsades De Pointes Induced By Amiodarone And Escitalopram Treatment
    Aktas, Mujdat
    Yilmaz, Huseyin Deniz
    Sit, Omer
    Sit, Yilmaz
    Atalay, Suleyman
    Yildiz, Suleyman Sezai
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 : S46 - S49
  • [37] Drug-induced torsades de pointes in one patient with congenital long QT syndrome
    Hsieh, MH
    Chen, SA
    Chiang, CE
    Tai, CT
    Lee, SH
    Wen, ZC
    Chang, MS
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 54 (01) : 85 - 88
  • [38] DRUG-INDUCED TORSADES-DE-POINTES - ROLE OF EARLY AFTERDEPOLARIZATIONS AND DISPERSION OF REPOLARIZATION
    HABBAB, MA
    ELSHERIF, N
    AMERICAN JOURNAL OF MEDICINE, 1990, 89 (02): : 241 - 246
  • [39] Evaluation of the QT interval in patients with drug-induced QT prolongation and torsades de pointes
    Krisai, Philipp
    Vlachos, Konstantinos
    Ramirez, F. Daniel
    Nakatani, Yosuke
    Nakashima, Takashi
    Takagi, Takamitsu
    Kamakura, Tsukasa
    Surget, Elodie
    Andre, Clementine
    Cheniti, Ghassen
    Welte, Nicolas
    Chauvel, Remi
    Tixier, Romain
    Duchateau, Josselin
    Pambrun, Thomas
    Derval, Nicolas
    Hocini, Meleze
    Jais, Pierre
    Hassaguerre, Michel
    Sacher, Frederic
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (10) : 2696 - 2701
  • [40] Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes
    Letsas, Konstantinos P.
    Efremidis, Michael
    Sideris, Antonlos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 124 (03) : 366 - 367